EUVIMEDEUVIMED entdecken
Open Access

Hematologic Abnormalities in Patients With Hidradenitis Suppurativa Receiving Adalimumab

Simon J Gunter, Zachary E Holcomb, Barbara D Lam, Martina L Porter, Alexa B Kimball

JAMA Dermatology · 2024

DOI: 10.1001/jamadermatol.2024.1075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Dermatology, 2024. Verfasst von Simon J Gunter und 4 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Adalimumab. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This post hoc analysis of PIONEER I and II randomized clinical trials assesses whether receiving adalimumab is associated with decreased hematologic abnormalities and increased clinical improvement in patients with hidradenitis suppurativa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaAdalimumabHumansFemaleMaleAdultMiddle AgedHematologic DiseasesAnti-Inflammatory Agents

Substanzen

AdalimumabAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Harvard Medical School, Boston, Massachusetts.
  • Section of Dermatology, Department of Medicine, Carilion Clinic, Roanoke, Virginia.
  • Division of Hematology and Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Department of Dermatology, Harvard Medical School, Boston, Massachusetts.

Zitieren

APA

Gunter, S. J., Holcomb, Z. E., Lam, B. D., Porter, M. L., & Kimball, A. B. (2024). Hematologic Abnormalities in Patients With Hidradenitis Suppurativa Receiving Adalimumab. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2024.1075

Vancouver

Gunter SJ, Holcomb ZE, Lam BD, Porter ML, Kimball AB. Hematologic Abnormalities in Patients With Hidradenitis Suppurativa Receiving Adalimumab. JAMA Dermatology. 2024. doi:10.1001/jamadermatol.2024.1075

BibTeX
@article{Gunter2024,
  author = {Gunter, Simon J and Holcomb, Zachary E and Lam, Barbara D and Porter, Martina L and Kimball, Alexa B},
  title = {Hematologic Abnormalities in Patients With Hidradenitis Suppurativa Receiving Adalimumab},
  journal = {JAMA Dermatology},
  year = {2024},
  doi = {10.1001/jamadermatol.2024.1075}
}
Kostenlos starten →